Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Feb 12, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new digital tool called gp-multitool.de, which helps doctors provide better care for patients with multiple health conditions, such as asthma, diabetes, and heart disease. The goal is to see if using this tool can improve how patients are treated in general practice settings in Germany. The trial is currently recruiting participants who are involved in specific disease management programs and have at least two additional health issues, like high blood pressure or chronic pain.

If you or a loved one are eligible, you can expect to use this digital tool during your regular visits to the doctor, which aims to provide personalized care based on your unique health needs. However, individuals who cannot consent to participate, have significant hearing or vision limitations, or do not speak enough German to communicate effectively will not be able to join the study. This trial is important because it seeks to improve healthcare for those with multiple conditions, ensuring they receive the best possible support and treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • participation in a disease management program (DMP); in Germany, DMPs have been implemented in outpatient care for asthma, breast neoplasms, coronary heart disease, diabetes mellitus type 1, diabetes mellitus type 2, chronic obstructive pulmonary disease, obesity, heart failure, chronic low back pain, depression, osteoporosis, rheumatoid arthritis
• • at least two of the following coexisting conditions: Hypertension, Lipid metabolism disorders, Chronic low back pain, Severe vision reduction, Joint arthrosis, Diabetes mellitus, Chronic ischemic heart disease, Thyroid dysfunction, Cardiac arrhythmias, Obesity, Hyperuricemia/Gout, Prostatic hyperplasia, Lower limb varicosis, Liver diseases, Depression, Asthma/Chronic obstructive pulmonary disease, Gynaecological problems, Atherosclerosis/Peripheral arterial occlusive disease, Osteoporosis, Renal insufficiency, Cerebral ischemia/Chronic stroke, Cardiac insufficiency, Severe hearing loss, Chronic cholecystitis/Gallstones, Somatoform disorders, Hemorrhoids, Intestinal diverticulosis, Rheumatoid arthritis/Chronic polyarthritis, Cardiac valve disorders, Neuropathies, Dizziness, Dementias, Urinary incontinence, Urinary tract calculi, Anemias, Anxiety, Psoriasis, Migraine/chronic headache, Parkinson's disease, Cancers, Allergies, Chronic gastritis/Gastroesophageal reflux disease, Sexual dysfunction, Insomnia, Tobacco abuse, Hypotension
• Exclusion Criteria:
• • no capacity to consent
• • functional limitations precluding participation in the intervention (eg, loss of vision)
• • functional limitations precluding participation in telephone interviews (eg, loss of hearing)
• • limited German language skills precluding participation in telephone interviews
• • participation in other trials during the observation time of the evaluation study